Critical evaluation of diagnostic aids for the detection of oral cancer

Oral Oncology

Volumn 44, Issue 1, 2008, Pages 10-22

  Lingen, Mark W ^a   Kalmar, John R ^b   Karrison, Theodore ^c   Speight, Paul M ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Diagnosis; Oral cancer; Premalignancy; Screening

Indexed keywords

TOLONIUM CHLORIDE;

AUTOFLUORESCENCE; AWARENESS; CANCER DIAGNOSIS; CANCER SCREENING; CYTOLOGY; DIAGNOSTIC PROCEDURE; EVALUATION; HUMAN; IMMUNOHISTOCHEMISTRY; MARKETING; MOUTH CANCER; MOUTH EXAMINATION; PRIORITY JOURNAL; REFLECTOMETRY; REVIEW; SYSTEMATIC REVIEW;

COLORING AGENTS; CYTOLOGICAL TECHNIQUES; FLUORESCENCE; HUMANS; MASS SCREENING; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; SPECTROPHOTOMETRY; TOLONIUM CHLORIDE;

EID: 37149017321     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.06.011     Document Type: Review

References (93)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 2 (2001) 153-156
2. American Cancer Society: Cancer Facts and Figures; 2005. .
3. SEER Cancer Statistics Review; 1973-1998. .
4. Day G.L., and Blot W.J. Second primary tumors in patients with oral cancer. Cancer 70 1 (1992) 14-19
5. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 5 (1953) 963-968
6. Lippman S.M., and Hong W.K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17 3 (1989) 691-694
7. Wilson JMG JY. Principles and practice of mass screening for disease. Public Health Pap, No. 34; 1968.
8. UK National Screening Committee, Criteria for appraising the viability, effectiveness and appropriateness of a Screening programme. .
9. Jaeschke R., Guyatt G., and Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-based medicine working group. JAMA 271 5 (1994) 389-391
10. Jaeschke R., Guyatt G.H., and Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA 271 9 (1994) 703-707
11. Sackett D.L.H.R., Guyatt G.H., and Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. (1991), Little Brown, Boston p. 53-7
12. Thomson D.M., Krupey J., Freedman S.O., and Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 64 1 (1969) 161-167
13. Ransohoff D.F., and Feinstein A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 299 17 (1978) 926-930
14. Bates S.E. Clinical applications of serum tumor markers. Ann Intern Med 115 8 (1991) 623-638
15. Whited J.D., and Grichnik J.M. The rational clinical examination. Does this patient have a mole or a melanoma?. JAMA 279 9 (1998) 696-701
16. Rampen F.H., Casparie-van Velsen J.I., van Huystee B.E., Kiemeney L.A., and Schouten L.J. False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol 33 1 (1995) 59-63
17. Shugars D.C., and Patton L.L. Detecting, diagnosing, and preventing oral cancer. Nurse Pract 22 6 (1997) 105 109-10, 113-5 passim
18. Silverman Jr. S. Early diagnosis of oral cancer. Cancer 62 8 Suppl (1988) 1796-1799
19. Sandler H.C. Cytological screening for early mouth cancer. Cancer 15 (1962) 1119-1124
20. Jullien J.A., Downer M.C., Zakrzewska J.M., and Speight P.M. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 12 1 (1995) 3-7
21. Downer M.C., Evans A.W., Hughes Hallet C.M., Jullien J.A., Speight P.M., and Zakrzewska J.M. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 23 2 (1995) 84-88
22. Downer M.C., Moles D.R., Palmer S., and Speight P.M. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol 40 3 (2004) 264-273
23. Warnakulasuriya K.A., and Nanayakkara B.G. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev 15 5 (1991) 331-334
24. Warnakulasuriya S., and Pindborg J.J. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health 7 1 (1990) 73-79
25. Mathew B., Sankaranarayanan R., Sunilkumar K.B., Kuruvila B., Pisani P., and Nair M.K. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 76 3 (1997) 390-394
26. Mehta F.S., Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., and Pindborg J.J. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 9 3-4 (1986) 219-225
27. Ikeda N., Downer M.C., Ishii T., Fukano H., Nagao T., and Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health 12 3 (1995) 133-137
28. Kujan O GA, Duxbury AJ, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer [Cochrane Database Syst Rev. 4, CD004150]; 2003.
29. Ramadas K., Sankaranarayanan R., Jacob B.J., Thomas G., Somanathan T., Mahe C., et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol 39 6 (2003) 580-588
30. Sankaranarayanan R., Mathew B., Jacob B.J., Thomas G., Somanathan T., Pisani P., et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 88 3 (2000) 664-673
31. Sankaranarayanan R., Ramadas K., Thomas G., Muwonge R., Thara S., Mathew B., et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365 9475 (2005) 1927-1933
32. Mignogna M.D., and Fedele S. Oral cancer screening: 5 minutes to save a life. Lancet 365 9475 (2005) 1905-1906
33. Downer M.C., Jullien J.A., and Speight P.M. An interim determination of health gain from oral cancer and precancer screening: 3. Preselecting high risk individuals. Community Dent Health 15 2 (1998) 72-76
34. Speight P.M., Palmer S., Moles D.R., Downer M.C., Smith D.H., Henriksson M., et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 10 14 (2006) 1-144 iii-iv
35. Burzynski N.J., Firriolo F.J., Butters J.M., and Sorrell C.L. Evaluation of oral cancer screening. J Cancer Educ 12 2 (1997) 95-99
36. Bouquot J.E. Common oral lesions found during a mass screening examination. J Am Dent Assoc 112 1 (1986) 50-57
37. Malaovalla A.M., Silverman S., Mani N.J., Bilimoria K.F., and Smith L.W. Oral cancer in 57,518 industrial workers of Gujarat, India: a prevalence and followup study. Cancer 37 4 (1976) 1882-1886
38. Thomson P.J. Field change and oral cancer: new evidence for widespread carcinogenesis?. Int J Oral Maxillofac Surg 31 3 (2002) 262-266
39. Frist S. The oral brush biopsy: separating fact from fiction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 6 (2003) 654-655
40. Eisen D. Brush biopsy 'saves lives'. J Am Dent Assoc 133 6 (2002) 688 690, 692
41. Eisen D., and Frist S. The relevance of the high positive predictive value of the oral brush biopsy. Oral Oncol 41 7 (2005) 753-755
42. Sciubba J.J. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study Group. J Am Dent Assoc 130 10 (1999) 1445-1457
43. Svirsky J.A., Burns J.C., Carpenter W.M., Cohen D.M., Bhattacharyya I., Fantasia J.E., et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 50 6 (2002) 500-503
44. Poate T.W., Buchanan J.A., Hodgson T.A., Speight P.M., Barrett A.W., Moles D.R., et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 40 8 (2004) 829-834
45. Potter T.J., Summerlin D.J., and Campbell J.H. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg 61 6 (2003) 674-677
46. Rick G.M. Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 3 (2003) 252
47. Christian D.C. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J Am Dent Assoc 133 3 (2002) 357-362
48. Scheifele C., Schmidt-Westhausen A.M., Dietrich T., and Reichart P.A. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 40 8 (2004) 824-828
49. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 106 3 (1983) 319-323
50. Gray MGL, Burls A, Elley K. The clinical effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. A West Midlands Development and Evaluation Service Report; 2000. .
51. Barrellier P., Babin E., Louis M.Y., and Meunier-Guttin A. The use of toluidine blue in the diagnosis of neoplastic lesions of the oral cavity. Rev Stomatol Chir Maxillofac 94 1 (1993) 51-54
52. Warnakulasuriya K.A., and Johnson N.W. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 25 3 (1996) 97-103
53. Onofre M.A., Sposto M.R., and Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 5 (2001) 535-540
54. Martin I.C., Kerawala C.J., and Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 4 (1998) 444-446
55. Zhang L., Williams M., Poh C.F., Laronde D., Epstein J.B., Durham S., et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65 17 (2005) 8017-8021
56. Gandolfo S., Pentenero M., Broccoletti R., Pagano M., Carrozzo M., and Scully C. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 42 1 (2006) 89-95
57. Huber M.A., Bsoul S.A., and Terezhalmy G.T. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 35 5 (2004) 378-384
58. Ram S., and Siar C.H. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34 5 (2005) 521-527
59. Epstein J.B., Gorsky M., Lonky S., Silverman Jr. S., Epstein J.D., and Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dent 26 4 (2006) 171-174
60. Kerr A.R., Sirois D.A., and Epstein J.B. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 17 3 (2006) 59-63
61. Farah C.S., and McCullough M.J. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLitetrade mark) in the visualisation of oral mucosal white lesions. Oral Oncol (2006)
62. Oh E.S., and Laskin D.M. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 65 3 (2007) 424-426
63. Lam S., MacAulay C., Hung J., LeRiche J., Profio A.E., and Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 105 6 (1993) 1035-1040
64. Onizawa K., Saginoya H., Furuya Y., and Yoshida H. Fluorescence photography as a diagnostic method for oral cancer. Cancer Lett 108 1 (1996) 61-66
65. Ingrams D.R., Dhingra J.K., Roy K., Perrault Jr. D.F., Bottrill I.D., Kabani S., et al. Autofluorescence characteristics of oral mucosa. Head Neck 19 1 (1997) 27-32
66. Gillenwater A., Jacob R., Ganeshappa R., Kemp B., El-Naggar A.K., Palmer J.L., et al. Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg 124 11 (1998) 1251-1258
67. Schantz S.P., Kolli V., Savage H.E., Yu G., Shah J.P., Harris D.E., et al. In vivo native cellular fluorescence and histological characteristics of head and neck cancer. Clin Cancer Res 4 5 (1998) 1177-1182
68. Kulapaditharom B., and Boonkitticharoen V. Laser-induced fluorescence imaging in localization of head and neck cancers. Ann Otol Rhinol Laryngol 107 3 (1998) 241-246
69. Inaguma M., and Hashimoto K. Porphyrin-like fluorescence in oral cancer: in vivo fluorescence spectral characterization of lesions by use of a near-ultraviolet excited autofluorescence diagnosis system and separation of fluorescent extracts by capillary electrophoresis. Cancer 86 11 (1999) 2201-2211
70. Onizawa K., Saginoya H., Furuya Y., Yoshida H., and Fukuda H. Usefulness of fluorescence photography for diagnosis of oral cancer. Int J Oral Maxillofac Surg 28 3 (1999) 206-210
71. Heintzelman D.L., Utzinger U., Fuchs H., Zuluaga A., Gossage K., Gillenwater A.M., et al. Optimal excitation wavelengths for in vivo detection of oral neoplasia using fluorescence spectroscopy. Photochem Photobiol 72 1 (2000) 103-113
72. Onizawa K., Yoshida H., and Saginoya H. Chromatic analysis of autofluorescence emitted from squamous cell carcinomas arising in the oral cavity: a preliminary study. Int J Oral Maxillofac Surg 29 1 (2000) 42-46
73. Kulapaditharom B., and Boonkitticharoen V. Performance characteristics of fluorescence endoscope in detection of head and neck cancers. Ann Otol Rhinol Laryngol 110 1 (2001) 45-52
74. Onizawa K., Okamura N., Saginoya H., Yusa H., Yanagawa T., and Yoshida H. Analysis of fluorescence in oral squamous cell carcinoma. Oral Oncol 38 4 (2002) 343-348
75. Betz C.S., Stepp H., Janda P., Arbogast S., Grevers G., Baumgartner R., et al. A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 97 2 (2002) 245-252
76. Muller M.G., Valdez T.A., Georgakoudi I., Backman V., Fuentes C., Kabani S., et al. Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 97 7 (2003) 1681-1692
77. Utzinger U., Bueeler M., Oh S., Heintzelman D.L., Svistun E.S., Abd-El-Barr M., et al. Optimal visual perception and detection of oral cavity neoplasia. IEEE Trans Biomed Eng 50 3 (2003) 396-399
78. Onizawa K., Okamura N., Saginoya H., and Yoshida H. Characterization of autofluorescence in oral squamous cell carcinoma. Oral Oncol 39 2 (2003) 150-156
79. Manjunath B.K., Kurein J., Rao L., Krishna C.M., Chidananda M.S., Venkatakrishna K., et al. Autofluorescence of oral tissue for optical pathology in oral malignancy. J Photochem Photobiol B 73 1-2 (2004) 49-58
80. Zheng W., Olivo M., and Soo K.C. The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo. Int J Cancer 110 2 (2004) 295-300
81. Svistun E., Alizadeh-Naderi R., El-Naggar A., Jacob R., Gillenwater A., and Richards-Kortum R. Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck 26 3 (2004) 205-215
82. Skala M.C., Squirrell J.M., Vrotsos K.M., Eickhoff J.C., Gendron-Fitzpatrick A., Eliceiri K.W., et al. Multiphoton microscopy of endogenous fluorescence differentiates normal, precancerous, and cancerous squamous epithelial tissues. Cancer Res 65 4 (2005) 1180-1186
83. De Veld D.C., Witjes M.J., Sterenborg H.J., and Roodenburg J.L. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 41 2 (2005) 117-131
84. Lane P.M., Gilhuly T., Whitehead P., Zeng H., Poh C.F., Ng S., et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 11 2 (2006) 024006
85. Poh C.F., Williams P.M., Zhang L., Laronde D.M., Lane P., MacAulay C., et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 29 1 (2007) 71-76
86. Poh C.F., Zhang L., Anderson D.W., Durham J.S., Williams P.M., Priddy R.W., et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 12 22 (2006) 6716-6722
87. Mashberg A., and Feldman L.J. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg 156 4 (1988) 273-275
88. Yellowitz J., Horowitz A.M., Goodman H.S., Canto M.T., and Farooq N.S. Knowledge, opinions and practices of general dentists regarding oral cancer: a pilot survey. J Am Dent Assoc 129 5 (1998) 579-583
89. Yellowitz J.A., Horowitz A.M., Drury T.F., and Goodman H.S. Survey of US dentists' knowledge and opinions about oral pharyngeal cancer. J Am Dent Assoc 131 5 (2000) 653-661
90. Horowitz A.M., Drury T.F., Goodman H.S., and Yellowitz J.A. Oral pharyngeal cancer prevention and early detection. Dentists' opinions and practices. J Am Dent Assoc 131 4 (2000) 453-462
91. Burzynski N.J., Rankin K.V., Silverman Jr. S., Scheetz J.P., and Jones D.L. Graduating dental students' perceptions of oral cancer education: results of an exit survey of seven dental schools. J Cancer Educ 17 2 (2002) 83-84
92. Horowitz A.M., Canto M.T., and Child W.L. Maryland adults' perspectives on oral cancer prevention and early detection. J Am Dent Assoc 133 8 (2002) 1058-1063
93. Stahl S., Meskin L.H., and Brown L.J. The American Dental Association's oral cancer campaign: the impact on consumers and dentists. J Am Dent Assoc 135 9 (2004) 1261-1267